Source link : https://www.newshealth.biz/health-news/tirzepatide-improves-sleep-apnea-in-patients-with-obesity-drugmaker-says/
Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials. In the SURMOUNT-OSA 1 study, focused on patients not using PAP treatment, tirzepatide lowered average apnea-hypopnea events by 27.4 per hour from baseline measurements versus the average 4.8-per-hour […]
Author : News Health
Publish date : 2024-04-18 19:34:22
Copyright for syndicated content belongs to the linked Source.